Highlights From ABT's Q1 Conference Call; Sees Uncertainty in U.S. Markets, But Guides In-line

April 15, 2009 2:02 PM EDT Send to a Friend
Abbott Laboratories (NYSE: ABT) reports Q1 EPS of $0.73, versus the consensus of $0.70. Revenues came in at $6.72, versus ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login